Afuco™ Anti-Human FCGR3B ADCC Therapeutic Antibody (GMA161), ADCC Enhanced

Anti-FCGR3B ADCC Enhanced Antibody (GMA161) is an ADCC enhanced antibody produced by our Afuco™ platform. GMA161 is an anti human CD16 (FcγRIII) monoclonal antibody for treatment of autoimmune disorders in CD16 transgenic mice.
Supplier Creative Biolabs
Product # AFC-257CL
Pricing Inquiry
Host Humanized
Target FCGR3B
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at -20°C for long-term storage. Store at 4°C for up to one month. Avoid freeze/thaw cycles.
Feedback